Fulgent Genetics, Inc. FLGT Stock-Based Comp
Stock-Based Comp at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Fulgent Genetics, Inc.'s stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Fulgent Genetics, Inc.'s stock-based comp?
- Fulgent Genetics, Inc. (FLGT) reported stock-based comp of $9.89M in Q1 2026.
- How has Fulgent Genetics, Inc.'s stock-based comp changed year-over-year?
- Fulgent Genetics, Inc.'s stock-based comp decreased by 6.3% year-over-year, from $10.55M to $9.89M.
- What is the long-term trend for Fulgent Genetics, Inc.'s stock-based comp?
- Over 4 years (2021 to 2025), Fulgent Genetics, Inc.'s stock-based comp has grown at a 25.6% compound annual growth rate (CAGR), from $15.88M to $39.58M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.